CRISPR Therapeutics (CRSP) Stock Jumps as U.K. Authorizes Gene Therapy
$CRISPR Therapeutics(CRSP.US$ won U.K. authorization for its treatment of sickle cell anemia.
Casgevy is now before the FDA and could offer a lifetime cure.
Casgevy is now before the FDA and could offer a lifetime cure.
$Vertex Pharmaceuticals(VRTX.US$ was CRISPR’s partner in development.
The Bottom Line on CRSP Stock
The U.K. decision won’t have a huge financial impact, but it could be the first of many. CRISPR has treatments for cancer, diabetes, and heart disease in its pipeline. The FDA decision, when it comes, will also move the stock.
The U.K. decision won’t have a huge financial impact, but it could be the first of many. CRISPR has treatments for cancer, diabetes, and heart disease in its pipeline. The FDA decision, when it comes, will also move the stock.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Master Corgi :
